Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
GHRH analog with Drug Affinity Complex · ~6-8 day half-life · Weekly dosing
GHRH analog covalently attached to a Drug Affinity Complex — extends serum half-life to approximately 8 days.
Per-lot analytical report — HPLC, ESI-MS, LAL endotoxin, heavy metals, sterility
Buy CJC-1295 DAC 5mg at IGF1 Shop. CJC-1295 with DAC bioconjugates with circulating albumin via a maleimidopropionic-acid linker (the Drug Affinity Complex), dramatically extending its serum half-life from minutes to approximately 6-8 days. This makes CJC-1295 DAC suitable for once or twice weekly dosing instead of the daily pulsatile schedule of the No-DAC version. Every CJC-1295 DAC 5mg vial is HPLC-verified at ≥99% purity, identity-confirmed by ESI mass-spec, and accompanied by a per-lot Certificate of Analysis from an ISO 17025-accredited lab.
Also known as: CJC-1295 DAC · CJC 1295 with DAC · CJC-1295 with DAC · Long-acting CJC-1295
CJC-1295 with DAC bioconjugates with circulating albumin via a maleimidopropionic linker, dramatically extending its in-vivo half-life. Used in protocols requiring sustained GHRH receptor activation rather than pulsatile stimulation.
Every lot of CJC-1295 (with DAC) is released only after passing reverse-phase HPLC (≥ 99% area purity at 220 nm against a reference standard), ESI mass spectrometry confirmation of molecular weight, and Limulus Amebocyte Lysate (LAL) endotoxin testing below 0.5 EU/mg. The lot-specific Certificate of Analysis is provided with the order and available on request before purchase.